VORICONAZOLE INJECTION

VORICONAZOLE INJECTION was reported 22090 times

VORICONAZOLE INJECTION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FLUORIDE INCREASED 36 0.6792
1 PERIOSTITIS 226 0.5231
2 FLUOROSIS 40 0.4651
3 CEREBRAL ASPERGILLOSIS 192 0.3122
4 HYPERTROPHIC OSTEOARTHROPATHY 21 0.3088
5 GEOTRICHUM INFECTION 61 0.2891
6 SCOPULARIOPSIS INFECTION 13 0.2889
7 SCEDOSPORIUM INFECTION 167 0.2365
8 MYCOTIC ENDOPHTHALMITIS 43 0.2275
9 FUSARIUM INFECTION 151 0.2157
10 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 47 0.2026
11 PERICARDITIS FUNGAL 13 0.1970
12 PHOTODERMATOSIS 82 0.1943
13 CHOROIDITIS 72 0.1925
14 DISSEMINATED TRICHOSPORONOSIS 13 0.1806
15 DISSEMINATED ASPERGILLOSIS 85 0.1801
16 DISSEMINATED MUCORMYCOSIS 69 0.1751
17 OSTEOMYELITIS FUNGAL 29 0.1737
18 FUNGAL ENDOCARDITIS 52 0.1728
19 KERATITIS FUNGAL 34 0.1635
20 PULMONARY MUCORMYCOSIS 84 0.1591
21 ENCEPHALITIS FUNGAL 13 0.1444
22 DILATATION INTRAHEPATIC DUCT ACQUIRED 42 0.1438
23 ASPERGILLOMA 45 0.1406
24 SYSTEMIC MYCOSIS 162 0.1387
25 ASPERGILLUS INFECTION 866 0.1318
26 TOXIC OPTIC NEUROPATHY 57 0.1313
27 ASPERGILLUS TEST POSITIVE 40 0.1299
28 MUCORMYCOSIS 333 0.1280
29 ABSCESS FUNGAL 22 0.1257
30 INTRACRANIAL INFECTION 15 0.1200
31 CHLOROPSIA 15 0.1172
32 BRONCHOPULMONARY ASPERGILLOSIS 897 0.1156
33 ZYGOMYCOSIS 51 0.1090
34 TRICHOSPORON INFECTION 44 0.1086
35 ACTINIC KERATOSIS 261 0.1005
36 HEPATIC INFECTION FUNGAL 12 0.1000
37 TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 18 0.0994
38 EYE INFECTION FUNGAL 38 0.0982
39 PHAEHYPHOMYCOSIS 13 0.0970
40 PHAEOHYPHOMYCOSIS 46 0.0960
41 ACANTHAMOEBA INFECTION 18 0.0957
42 HEPATOSPLENIC CANDIDIASIS 14 0.0952
43 DYSPLASTIC NAEVUS 34 0.0942
44 ALTERNARIA INFECTION 34 0.0914
45 MICROSPORIDIA INFECTION 32 0.0912
46 GASTROINTESTINAL MUCORMYCOSIS 15 0.0898
47 CEREBRAL FUNGAL INFECTION 25 0.0883
48 DEHISCENCE 16 0.0847
49 SINUSITIS ASPERGILLUS 13 0.0823
50 DISSEMINATED BLASTOMYCOSIS 14 0.0819
51 CYSTITIS VIRAL 29 0.0757
52 LOWER RESPIRATORY TRACT INFECTION FUNGAL 29 0.0746
53 IDIOPATHIC PNEUMONIA SYNDROME 22 0.0738
54 SKIN CANDIDA 37 0.0709
55 FUNGAEMIA 100 0.0635
56 SOLAR LENTIGO 60 0.0632
57 ASPERGILLOSIS 81 0.0620
58 PNEUMONIA FUNGAL 236 0.0598
59 FUNGAL TEST POSITIVE 20 0.0570
60 MEDIASTINITIS 33 0.0569
61 INFECTIVE ANEURYSM 28 0.0566
62 PNEUMOCYSTIS JIROVECII INFECTION 67 0.0561
63 RHINOCEREBRAL MUCORMYCOSIS 19 0.0548
64 GALLBLADDER OEDEMA 16 0.0546
65 SQUAMOUS CELL CARCINOMA OF SKIN 307 0.0508
66 BRAIN ABSCESS 126 0.0497
67 PRODUCT COMPOUNDING QUALITY ISSUE 18 0.0493
68 EYE ABSCESS 15 0.0492
69 XANTHOPSIA 18 0.0488
70 DISORGANISED SPEECH 89 0.0482
71 GRAFT VERSUS HOST DISEASE IN LUNG 23 0.0481
72 RESPIRATORY TRACT INFECTION FUNGAL 25 0.0473
73 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 66 0.0467
74 CITROBACTER INFECTION 20 0.0466
75 BLOOD BETA-D-GLUCAN INCREASED 14 0.0456
76 TRACHEOBRONCHITIS 34 0.0442
77 SINUSITIS FUNGAL 35 0.0436
78 HUMAN POLYOMAVIRUS INFECTION 23 0.0433
79 PNEUMONIA NECROTISING 28 0.0433
80 SEPTIC EMBOLUS 36 0.0433
81 STENOTROPHOMONAS INFECTION 58 0.0427
82 POLYSEROSITIS 18 0.0423
83 DYSCHROMATOPSIA 35 0.0422
84 UREAPLASMA INFECTION 17 0.0417
85 DISSEMINATED CRYPTOCOCCOSIS 31 0.0410
86 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 29 0.0403
87 GLIOSIS 17 0.0396
88 LENTIGO 19 0.0383
89 ENTEROCOCCAL SEPSIS 31 0.0383
90 PSEUDOPORPHYRIA 13 0.0380
91 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 104 0.0376
92 OVARIAN FAILURE 20 0.0374
93 PARVOVIRUS INFECTION 15 0.0371
94 DYSBIOSIS 30 0.0365
95 CORNEAL PERFORATION 23 0.0365
96 URINARY TRACT INFLAMMATION 13 0.0361
97 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 119 0.0360
98 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 76 0.0357
99 VIRAL HAEMORRHAGIC CYSTITIS 25 0.0351
100 BLASTOMYCOSIS 17 0.0350
101 INFECTION IN AN IMMUNOCOMPROMISED HOST 25 0.0348
102 GRAFT VERSUS HOST DISEASE IN SKIN 76 0.0345
103 DRUG LEVEL BELOW THERAPEUTIC 187 0.0339
104 PULMONARY MYCOSIS 26 0.0334
105 PULMONARY CAVITATION 29 0.0333
106 LUNG TRANSPLANT REJECTION 22 0.0333
107 ENTEROCOCCAL BACTERAEMIA 35 0.0330
108 NECROTISING RETINITIS 20 0.0312
109 MYCOBACTERIUM ABSCESSUS INFECTION 22 0.0308
110 GRAFT VERSUS HOST DISEASE 220 0.0306
111 TOXOPLASMOSIS 33 0.0306
112 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 28 0.0302
113 ECTHYMA 12 0.0299
114 ACUTE MYELOID LEUKAEMIA RECURRENT 64 0.0298
115 PHOTOSENSITIVITY REACTION 461 0.0279
116 DRUG LEVEL INCREASED 455 0.0275
117 GASTROINTESTINAL FUNGAL INFECTION 14 0.0272
118 RENAL ABSCESS 22 0.0269
119 ACINETOBACTER INFECTION 29 0.0265
120 RETINAL ISCHAEMIA 16 0.0262
121 DRUG LEVEL ABOVE THERAPEUTIC 120 0.0262
122 PATHOGEN RESISTANCE 237 0.0260
123 ENTEROCOCCAL INFECTION 125 0.0258
124 PROCALCITONIN INCREASED 30 0.0256
125 ENDOPHTHALMITIS 153 0.0255
126 PNEUMONIA PSEUDOMONAL 39 0.0254
127 FUNGAL SEPSIS 21 0.0253
128 PRODUCT CONTAMINATION MICROBIAL 30 0.0251
129 INFECTIOUS PLEURAL EFFUSION 38 0.0250
130 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 23 0.0248
131 SYSTEMIC CANDIDA 61 0.0243
132 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 19 0.0241
133 GRAFT VERSUS HOST DISEASE IN LIVER 17 0.0237
134 MULTIPLE ORGAN DYSFUNCTION SYNDROME 667 0.0235
135 DRUG RESISTANCE 599 0.0233
136 PSEUDOMONAS INFECTION 188 0.0219
137 INFECTION REACTIVATION 25 0.0218
138 LEUKAEMIA RECURRENT 36 0.0213
139 PSEUDOMONAL BACTERAEMIA 18 0.0211
140 POUCHITIS 18 0.0209
141 CYTOMEGALOVIRUS VIRAEMIA 93 0.0209
142 CYTOMEGALOVIRUS ENTEROCOLITIS 16 0.0208
143 PULMONARY NOCARDIOSIS 17 0.0206
144 T-LYMPHOCYTE COUNT DECREASED 14 0.0205
145 DIFFERENTIATION SYNDROME 15 0.0204
146 CHORIORETINITIS 13 0.0202
147 COCCIDIOIDOMYCOSIS 24 0.0201
148 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 24 0.0200
149 NEUROLOGICAL DECOMPENSATION 46 0.0199
150 ACUTE GRAFT VERSUS HOST DISEASE 90 0.0196
151 BK VIRUS INFECTION 66 0.0195
152 NOCARDIOSIS 50 0.0195
153 PNEUMOMEDIASTINUM 35 0.0193
154 APALLIC SYNDROME 14 0.0193
155 VENOOCCLUSIVE LIVER DISEASE 94 0.0190
156 SQUAMOUS CELL CARCINOMA 176 0.0187
157 LUNG ABSCESS 39 0.0186
158 KLEBSIELLA INFECTION 94 0.0186
159 HEPATOTOXICITY 413 0.0185
160 PNEUMONIA CYTOMEGALOVIRAL 36 0.0185
161 PREMATURE MENOPAUSE 17 0.0184
162 DRUG CLEARANCE DECREASED 24 0.0184
163 CYTOMEGALOVIRUS INFECTION REACTIVATION 81 0.0183
164 HALLUCINATION, VISUAL 383 0.0181
165 OCULAR TOXICITY 20 0.0181
166 BRAIN HERNIATION 54 0.0181
167 KLEBSIELLA BACTERAEMIA 17 0.0179
168 KLEBSIELLA SEPSIS 20 0.0177
169 CHROMATOPSIA 13 0.0171
170 PSEUDOMONAS TEST POSITIVE 14 0.0171
171 PNEUMONIA CRYPTOCOCCAL 16 0.0169
172 MUCOSAL ULCERATION 17 0.0168
173 DRUG LEVEL DECREASED 171 0.0168
174 OBLITERATIVE BRONCHIOLITIS 22 0.0168
175 MYCOPLASMA INFECTION 13 0.0166
176 ADENOVIRUS INFECTION 48 0.0165
177 SUPERINFECTION BACTERIAL 13 0.0164
178 FUNGAL SKIN INFECTION 65 0.0161
179 LUNG CONSOLIDATION 45 0.0161
180 GASTROINTESTINAL WALL THICKENING 24 0.0160
181 MIXED LIVER INJURY 48 0.0159
182 INTRACRANIAL MASS 15 0.0159
183 CHRONIC GRAFT VERSUS HOST DISEASE 57 0.0158
184 SOMATIC SYMPTOM DISORDER 17 0.0157
185 CRYPTOCOCCOSIS 25 0.0153
186 CHOLESTATIC LIVER INJURY 34 0.0153
187 CYTOMEGALOVIRUS TEST POSITIVE 27 0.0151
188 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 77 0.0151
189 STRONGYLOIDIASIS 24 0.0148
190 CEREBRAL ARTERY EMBOLISM 18 0.0148
191 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 38 0.0147
192 POTENTIATING DRUG INTERACTION 49 0.0146
193 CAPILLARY LEAK SYNDROME 30 0.0145
194 HYPOPYON 12 0.0145
195 NEUROPSYCHIATRIC SYMPTOMS 13 0.0144
196 HUMAN HERPESVIRUS 6 INFECTION 27 0.0143
197 PSEUDOMONAL SEPSIS 25 0.0143
198 HALO VISION 16 0.0141
199 MYCOBACTERIUM AVIUM COMPLEX INFECTION 38 0.0141
200 NEUROTOXICITY 248 0.0141
201 FUNGAL INFECTION 470 0.0141
202 SEPTIC SHOCK 602 0.0138
203 LABELLED DRUG-DRUG INTERACTION ISSUE 20 0.0138
204 BACTERIAL SEPSIS 45 0.0138
205 NEPHROPATHY TOXIC 152 0.0135
206 ACUTE LUNG INJURY 16 0.0135
207 NECROTISING COLITIS 17 0.0134
208 CYSTITIS HAEMORRHAGIC 54 0.0134
209 NEUROENDOCRINE CARCINOMA OF THE SKIN 13 0.0133
210 ESCHERICHIA BACTERAEMIA 31 0.0132
211 VENOOCCLUSIVE DISEASE 33 0.0132
212 PARAINFLUENZAE VIRUS INFECTION 20 0.0131
213 DRUG INTERACTION 2063 0.0130
214 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 96 0.0128
215 PULMONARY ALVEOLAR HAEMORRHAGE 71 0.0126
216 INHIBITORY DRUG INTERACTION 20 0.0126
217 NEUTROPENIC SEPSIS 90 0.0126
218 NEUTROPENIC COLITIS 26 0.0126
219 ENTEROBACTER INFECTION 21 0.0125
220 ACUTE MYELOID LEUKAEMIA 194 0.0124
221 HYPERTRANSAMINASAEMIA 86 0.0124
222 HEPATIC CYTOLYSIS 157 0.0123
223 CARDIOVASCULAR INSUFFICIENCY 20 0.0123
224 CENTRAL NERVOUS SYSTEM INFECTION 14 0.0122
225 LUNG OPACITY 32 0.0121
226 COMA SCALE ABNORMAL 35 0.0121
227 CANDIDA INFECTION 204 0.0121
228 EMPYEMA 24 0.0121
229 MENINGITIS CRYPTOCOCCAL 21 0.0120
230 STREPTOCOCCAL BACTERAEMIA 13 0.0119
231 HISTOPLASMOSIS 21 0.0119
232 PNEUMONIA INFLUENZAL 14 0.0118
233 HEPATOSPLENOMEGALY 30 0.0117
234 MULTIPLE-DRUG RESISTANCE 36 0.0116
235 ENTHESOPATHY 18 0.0115
236 CYTOMEGALOVIRUS INFECTION 191 0.0115
237 COMPLICATIONS OF TRANSPLANTED KIDNEY 26 0.0115
238 FEBRILE NEUTROPENIA 756 0.0114
239 LARGE INTESTINE INFECTION 14 0.0114
240 ACUTE LYMPHOCYTIC LEUKAEMIA 32 0.0113
241 HEPATITIS CHOLESTATIC 68 0.0113
242 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 30 0.0113
243 BONE MARROW TRANSPLANT 21 0.0111
244 HYPOPROTEINAEMIA 21 0.0111
245 BRONCHIAL SECRETION RETENTION 14 0.0110
246 TORSADE DE POINTES 86 0.0110
247 SUSPECTED OFF LABEL USE 49 0.0108
248 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 59 0.0108
249 CHOLESTASIS 204 0.0106
250 PNEUMONIA LEGIONELLA 17 0.0106
251 ANTIPHOSPHOLIPID SYNDROME 17 0.0106
252 RHINOVIRUS INFECTION 41 0.0105
253 MYCOBACTERIAL INFECTION 18 0.0104
254 HYPERLACTACIDAEMIA 28 0.0104
255 ESCHERICHIA SEPSIS 30 0.0103
256 PNEUMONIA KLEBSIELLA 19 0.0103
257 STAPHYLOCOCCAL SEPSIS 51 0.0103
258 LIP ULCERATION 12 0.0103
259 NECROSIS 57 0.0102
260 ACUTE RESPIRATORY DISTRESS SYNDROME 180 0.0102
261 TRANSPLANT DYSFUNCTION 18 0.0101
262 PULMONARY HAEMORRHAGE 78 0.0100
263 STAPHYLOCOCCAL BACTERAEMIA 43 0.0099
264 GRANULOMA 34 0.0098
265 TRANSPLANT FAILURE 24 0.0098
266 SPUTUM INCREASED 21 0.0097
267 BURNS SECOND DEGREE 17 0.0097
268 PNEUMONIA STAPHYLOCOCCAL 19 0.0096
269 PNEUMONIA BACTERIAL 88 0.0096
270 FORCED EXPIRATORY VOLUME DECREASED 27 0.0095
271 HALLUCINATIONS, MIXED 40 0.0095
272 RESPIRATORY FAILURE 692 0.0095
273 APRAXIA 14 0.0094
274 SKIN NECROSIS 49 0.0094
275 DEVICE RELATED SEPSIS 19 0.0094
276 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 47 0.0094
277 SOFT TISSUE INFECTION 17 0.0093
278 CYTOMEGALOVIRUS CHORIORETINITIS 18 0.0092
279 VENOUS THROMBOSIS LIMB 19 0.0092
280 INTERVERTEBRAL DISCITIS 17 0.0090
281 METABOLIC ENCEPHALOPATHY 27 0.0090
282 LUNG INFILTRATION 79 0.0089
283 TOXIC ENCEPHALOPATHY 45 0.0089
284 STEM CELL TRANSPLANT 22 0.0088
285 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 83 0.0087
286 INFLAMMATORY MARKER INCREASED 43 0.0087
287 HYPERAMMONAEMIA 43 0.0086
288 HYPERBILIRUBINAEMIA 89 0.0086
289 NEUROLOGICAL SYMPTOM 49 0.0086
290 DRUG-INDUCED LIVER INJURY 267 0.0085
291 ATYPICAL MYCOBACTERIAL INFECTION 12 0.0085
292 TRANSPLANT REJECTION 68 0.0085
293 HYPOPHOSPHATAEMIA 62 0.0084
294 SINUS ARREST 13 0.0083
295 PANCYTOPENIA 463 0.0083
296 BLOOD IMMUNOGLOBULIN E INCREASED 20 0.0083
297 HISTOPLASMOSIS DISSEMINATED 13 0.0082
298 RESPIRATORY ACIDOSIS 32 0.0081
299 HAEMODYNAMIC INSTABILITY 62 0.0081
300 CHEILITIS 44 0.0081
301 BASAL CELL CARCINOMA 123 0.0079
302 PULMONARY MASS 117 0.0078
303 SYSTEMIC INFECTION 13 0.0078
304 CYTOPENIA 96 0.0078
305 OLIGURIA 48 0.0077
306 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 18 0.0077
307 BLOOD CULTURE POSITIVE 23 0.0077
308 DISSEMINATED INTRAVASCULAR COAGULATION 108 0.0077
309 ILEUS PARALYTIC 34 0.0076
310 STAPHYLOCOCCUS TEST POSITIVE 16 0.0076
311 MULTI-ORGAN FAILURE 131 0.0076
312 OTOTOXICITY 14 0.0076
313 BRAIN OEDEMA 95 0.0075
314 LEUKOENCEPHALOPATHY 28 0.0075
315 CARDIAC TAMPONADE 35 0.0074
316 RENAL TUBULAR ACIDOSIS 16 0.0073
317 CYTOKINE RELEASE SYNDROME 147 0.0073
318 THROMBOTIC MICROANGIOPATHY 71 0.0073
319 APLASTIC ANAEMIA 38 0.0073
320 ORGANISING PNEUMONIA 36 0.0073
321 BACTERAEMIA 86 0.0072
322 HAEMOTHORAX 21 0.0072
323 HERPES SIMPLEX 47 0.0072
324 EPSTEIN-BARR VIRUS INFECTION 45 0.0072
325 PSEUDOMEMBRANOUS COLITIS 16 0.0072
326 VENTRICULAR HYPOKINESIA 23 0.0072
327 APLASIA 14 0.0071
328 LUNG INFECTION 111 0.0071
329 DYSPHORIA 36 0.0071
330 CLOSTRIDIUM DIFFICILE COLITIS 75 0.0071
331 TUMOUR LYSIS SYNDROME 62 0.0070
332 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 71 0.0069
333 BILIRUBIN CONJUGATED INCREASED 16 0.0068
334 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 12 0.0068
335 ORGAN FAILURE 27 0.0067
336 ENCEPHALITIS 46 0.0066
337 HYPERCAPNIA 20 0.0066
338 PULMONARY FUNCTION TEST DECREASED 29 0.0066
339 TORTICOLLIS 14 0.0066
340 ULCERATIVE KERATITIS 18 0.0066
341 ELECTROCARDIOGRAM QT PROLONGED 236 0.0066
342 PNEUMOTHORAX 104 0.0066
343 STUPOR 21 0.0065
344 HEPATITIS TOXIC 17 0.0065
345 CYTOMEGALOVIRUS COLITIS 15 0.0065
346 LUNG TRANSPLANT 23 0.0065
347 LIVER ABSCESS 21 0.0065
348 HYPOMAGNESAEMIA 90 0.0065
349 MUCOSAL INFLAMMATION 169 0.0064
350 HISTIOCYTOSIS HAEMATOPHAGIC 19 0.0064
351 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 349 0.0064
352 IMMUNOSUPPRESSION 56 0.0063
353 HYPOXIA 223 0.0063
354 HEPATOCELLULAR INJURY 89 0.0063
355 PNEUMOCYSTIS JIROVECII PNEUMONIA 63 0.0063
356 ABDOMINAL INFECTION 16 0.0063
357 ENDOCARDITIS 32 0.0062
358 CACHEXIA 32 0.0062
359 HEPATIC FUNCTION ABNORMAL 232 0.0062
360 HAEMOPTYSIS 171 0.0061
361 TRANSAMINASES INCREASED 136 0.0061
362 FUNCTIONAL GASTROINTESTINAL DISORDER 21 0.0061
363 HYPERNATRAEMIA 30 0.0060
364 HYPOKALAEMIA 274 0.0059
365 PHOTOPSIA 37 0.0058
366 BLOOD BILIRUBIN INCREASED 158 0.0058
367 PARESIS 13 0.0058
368 ENCEPHALOPATHY 143 0.0058
369 LYMPHOPENIA 82 0.0058
370 HYPOGAMMAGLOBULINAEMIA 38 0.0058
371 RALES 33 0.0057
372 THROMBOTIC THROMBOCYTOPENIC PURPURA 20 0.0057
373 CUSHINGOID 18 0.0056
374 UVEITIS 76 0.0056
375 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 13 0.0056
376 HALLUCINATION 421 0.0056
377 BONE MARROW FAILURE 113 0.0056
378 DELIRIUM 192 0.0055
379 BLOOD ALKALINE PHOSPHATASE INCREASED 137 0.0055
380 GASTRIC PERFORATION 15 0.0055
381 HYDROCEPHALUS 30 0.0055
382 TREATMENT FAILURE 456 0.0055
383 CANDIDIASIS 22 0.0055
384 TRANSPLANT 13 0.0055
385 CORNEAL DISORDER 12 0.0055
386 CHOLECYSTITIS ACUTE 31 0.0055
387 ESCHERICHIA INFECTION 45 0.0055
388 DISSEMINATED TUBERCULOSIS 14 0.0055
389 LONG QT SYNDROME 13 0.0054
390 CYSTIC FIBROSIS 30 0.0054
391 LIVER INJURY 133 0.0054
392 GAMMA-GLUTAMYLTRANSFERASE INCREASED 120 0.0054
393 INTRAOCULAR PRESSURE INCREASED 69 0.0054
394 STAPHYLOCOCCAL INFECTION 178 0.0054
395 DERMATITIS EXFOLIATIVE 27 0.0054
396 BACTERIAL TEST POSITIVE 12 0.0054
397 ORAL INFECTION 21 0.0054
398 MENTAL STATUS CHANGES 149 0.0054
399 RENAL TUBULAR DISORDER 15 0.0053
400 HYPOALBUMINAEMIA 41 0.0053
401 ACIDOSIS 40 0.0052
402 CHEST X-RAY ABNORMAL 16 0.0052
403 ATELECTASIS 50 0.0052
404 RASH MACULO-PAPULAR 115 0.0052
405 BACTERIAL INFECTION 96 0.0051
406 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 45 0.0051
407 TACHYPNOEA 69 0.0051
408 CEREBRAL ISCHAEMIA 26 0.0050
409 SUBCUTANEOUS ABSCESS 24 0.0050
410 HEMIPARESIS 83 0.0049
411 CENTRAL NERVOUS SYSTEM LESION 67 0.0049
412 ARTHRITIS BACTERIAL 20 0.0049
413 TOXIC SKIN ERUPTION 49 0.0049
414 COAGULOPATHY 81 0.0049
415 RESPIRATORY DISTRESS 133 0.0048
416 PERIPHERAL SENSORY NEUROPATHY 28 0.0048
417 RETINAL HAEMORRHAGE 34 0.0048
418 BRONCHIECTASIS 32 0.0047
419 LIVER FUNCTION TEST ABNORMAL 138 0.0047
420 ELECTROLYTE IMBALANCE 55 0.0047
421 PLEURAL EFFUSION 288 0.0047
422 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 18 0.0047
423 PLEURITIC PAIN 13 0.0047
424 AGRANULOCYTOSIS 87 0.0047
425 AUTOIMMUNE HAEMOLYTIC ANAEMIA 16 0.0047
426 HYPERURICAEMIA 19 0.0046
427 HYPERKALAEMIA 162 0.0046
428 EYE INJURY 14 0.0046
429 DERMATITIS BULLOUS 33 0.0046
430 NEUTROPENIA 618 0.0045
431 LIP PAIN 13 0.0045
432 ACUTE RESPIRATORY FAILURE 87 0.0045
433 INTRACRANIAL PRESSURE INCREASED 25 0.0045
434 SHOCK 103 0.0045
435 CEREBRAL HAEMATOMA 15 0.0045
436 IRIDOCYCLITIS 14 0.0044
437 LIP BLISTER 12 0.0044
438 SEPSIS 490 0.0044
439 BRONCHOPNEUMONIA 15 0.0044
440 HEPATOMEGALY 43 0.0044
441 ATYPICAL PNEUMONIA 13 0.0043
442 LEFT VENTRICULAR DYSFUNCTION 29 0.0043
443 SKIN INFECTION 48 0.0043
444 ALTERED STATE OF CONSCIOUSNESS 92 0.0042
445 VENTRICULAR EXTRASYSTOLES 44 0.0042
446 ABSCESS LIMB 18 0.0042
447 MALABSORPTION 22 0.0042
448 MYOCLONUS 50 0.0042
449 ACUTE HEPATIC FAILURE 57 0.0042
450 SINUS TACHYCARDIA 59 0.0042
451 NEUTROPHIL COUNT DECREASED 168 0.0041
452 PERICARDIAL EFFUSION 94 0.0041
453 BLOOD MAGNESIUM DECREASED 35 0.0041
454 ADRENAL INSUFFICIENCY 49 0.0040
455 OESOPHAGITIS 44 0.0040
456 MYELODYSPLASTIC SYNDROME 58 0.0040
457 AZOTAEMIA 16 0.0040
458 PULMONARY TUBERCULOSIS 17 0.0040
459 VASCULAR DEVICE INFECTION 18 0.0040
460 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 20 0.0039
461 GUILLAIN-BARRE SYNDROME 19 0.0039
462 LEUKOPENIA 196 0.0039
463 C-REACTIVE PROTEIN INCREASED 142 0.0039
464 TOXIC EPIDERMAL NECROLYSIS 59 0.0039
465 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 23 0.0039
466 ACUTE KIDNEY INJURY 590 0.0039
467 COVID-19 PNEUMONIA 45 0.0038
468 PSYCHIATRIC SYMPTOM 28 0.0038
469 SERUM FERRITIN INCREASED 20 0.0038
470 NERVOUS SYSTEM DISORDER 118 0.0038
471 VENTRICULAR TACHYCARDIA 62 0.0038
472 LUNG NEOPLASM 16 0.0037
473 RENAL IMPAIRMENT 314 0.0037
474 ANURIA 32 0.0037
475 DISEASE PROGRESSION 438 0.0037
476 SKIN LESION 101 0.0037
477 JAUNDICE CHOLESTATIC 13 0.0037
478 SUPRAVENTRICULAR TACHYCARDIA 35 0.0037
479 MYELOSUPPRESSION 131 0.0036
480 ASPARTATE AMINOTRANSFERASE INCREASED 193 0.0036
481 HEPATIC FAILURE 109 0.0036
482 HEPATIC ENZYME ABNORMAL 18 0.0036
483 MENINGITIS 24 0.0036
484 ALANINE AMINOTRANSFERASE INCREASED 219 0.0036
485 VISUAL ACUITY REDUCED 118 0.0035
486 SKIN TOXICITY 20 0.0035
487 BLOOD CREATININE INCREASED 231 0.0035
488 FEBRILE BONE MARROW APLASIA 15 0.0035
489 CEREBRAL HAEMORRHAGE 126 0.0035
490 SUNBURN 26 0.0035
491 HEMIPLEGIA 29 0.0035
492 ISCHAEMIA 16 0.0035
493 SKIN MASS 23 0.0034
494 SHOCK HAEMORRHAGIC 28 0.0034
495 ENTERITIS 22 0.0034
496 BLOOD LACTATE DEHYDROGENASE INCREASED 53 0.0033
497 DEVICE RELATED INFECTION 51 0.0033
498 THROMBOCYTOPENIA 365 0.0033
499 RHABDOMYOLYSIS 136 0.0033
500 LEUKOCYTOSIS 59 0.0033
501 HYPERCALCAEMIA 40 0.0032
502 HEPATITIS ACUTE 21 0.0032
503 ABDOMINAL TENDERNESS 16 0.0032
504 LUPUS-LIKE SYNDROME 29 0.0032
505 CHRONIC SINUSITIS 12 0.0032
506 ASCITES 93 0.0032
507 AUTOIMMUNE HEPATITIS 22 0.0032
508 METABOLIC ACIDOSIS 101 0.0032
509 OSTEOMYELITIS 57 0.0031
510 NORMAL NEWBORN 17 0.0031
511 ENTEROCOLITIS 18 0.0031
512 PYREXIA 1074 0.0031
513 DEPRESSED LEVEL OF CONSCIOUSNESS 121 0.0031
514 DRUG INEFFECTIVE 4031 0.0031
515 PARTIAL SEIZURES 16 0.0031
516 STREPTOCOCCAL INFECTION 17 0.0031
517 THERAPY NON-RESPONDER 137 0.0030
518 HYPONATRAEMIA 171 0.0030
519 PHOTOPHOBIA 57 0.0030
520 MYOPATHY 26 0.0030
521 PROTHROMBIN TIME PROLONGED 18 0.0030
522 POLYNEUROPATHY 36 0.0030
523 PLATELET COUNT DECREASED 320 0.0030
524 VENTRICULAR FIBRILLATION 33 0.0030
525 FLUID OVERLOAD 43 0.0030
526 CHRONIC LYMPHOCYTIC LEUKAEMIA 14 0.0029
527 CIRCULATORY COLLAPSE 50 0.0029
528 BLOOD UREA INCREASED 49 0.0029
529 RENAL FAILURE ACUTE 124 0.0029
530 NEPHROTIC SYNDROME 20 0.0029
531 SEROTONIN SYNDROME 56 0.0029
532 VISUAL FIELD DEFECT 21 0.0029
533 BLOOD ALBUMIN DECREASED 23 0.0029
534 CONDITION AGGRAVATED 879 0.0029
535 FAILURE TO THRIVE 15 0.0029
536 PERIORBITAL OEDEMA 15 0.0029
537 ATAXIA 34 0.0029
538 PNEUMONITIS 78 0.0029
539 DIFFUSE LARGE B-CELL LYMPHOMA 22 0.0029
540 ACUTE PULMONARY OEDEMA 16 0.0028
541 LIVER FUNCTION TEST INCREASED 61 0.0028
542 SPLENOMEGALY 33 0.0028
543 PNEUMONIA 911 0.0028
544 HAEMORRHAGE INTRACRANIAL 42 0.0028
545 CARDIOTOXICITY 25 0.0028
546 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 23 0.0028
547 PETECHIAE 29 0.0028
548 HERPES VIRUS INFECTION 16 0.0028
549 HEPATIC LESION 12 0.0028
550 ABSCESS 44 0.0028
551 LEUKAEMIA 26 0.0028
552 MOUTH ULCERATION 58 0.0027
553 RESPIRATORY TRACT INFECTION 71 0.0027
554 HAEMOLYSIS 21 0.0027
555 PRODUCT USE IN UNAPPROVED INDICATION 667 0.0027
556 MYOSITIS 24 0.0027
557 DRUG ERUPTION 47 0.0026
558 EMBOLISM 22 0.0026
559 RESPIRATORY SYNCYTIAL VIRUS INFECTION 23 0.0026
560 NEUTROPHIL COUNT INCREASED 27 0.0026
561 BREATH SOUNDS ABNORMAL 13 0.0026
562 PANCREATITIS ACUTE 59 0.0026
563 IMMUNE THROMBOCYTOPENIA 12 0.0026
564 COMPRESSION FRACTURE 14 0.0026
565 LYMPHOCYTE COUNT DECREASED 46 0.0026
566 MALNUTRITION 29 0.0026
567 HYPOCALCAEMIA 49 0.0026
568 FACIAL PARALYSIS 22 0.0026
569 HYPERGLYCAEMIA 94 0.0026
570 CEREBRAL INFARCTION 63 0.0026
571 TRANSFUSION 27 0.0026
572 RENAL FAILURE 342 0.0026
573 HYPERTRIGLYCERIDAEMIA 15 0.0026
574 CARDIAC FAILURE ACUTE 17 0.0025
575 MENTAL DISORDER 111 0.0025
576 RENAL TUBULAR NECROSIS 25 0.0025
577 HAEMATOTOXICITY 24 0.0025
578 HEPATIC ENZYME INCREASED 172 0.0025
579 CLOSTRIDIUM DIFFICILE INFECTION 55 0.0025
580 PERITONITIS 52 0.0025
581 LUNG DISORDER 123 0.0025
582 ATRIAL FLUTTER 20 0.0025
583 HAEMODIALYSIS 21 0.0025
584 ILEUS 31 0.0025
585 RESPIRATORY RATE INCREASED 22 0.0025
586 GENERALISED TONIC-CLONIC SEIZURE 41 0.0025
587 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 15 0.0025
588 WOUND INFECTION 27 0.0025
589 HEPATITIS 63 0.0025
590 SUBARACHNOID HAEMORRHAGE 25 0.0025
591 HOSPICE CARE 24 0.0024
592 SPUTUM DISCOLOURED 23 0.0024
593 GENERALISED OEDEMA 30 0.0024
594 OFF LABEL USE 2121 0.0024
595 INFECTION 350 0.0024
596 HALLUCINATION, AUDITORY 38 0.0024
597 VISUAL IMPAIRMENT 296 0.0024
598 RESPIRATORY DISORDER 71 0.0024
599 PRODUCTIVE COUGH 113 0.0024
600 PLEURISY 14 0.0024
601 HEPATIC ENCEPHALOPATHY 22 0.0024
602 NEPHROPATHY 22 0.0024
603 HAEMOLYTIC ANAEMIA 21 0.0023
604 ECCHYMOSIS 16 0.0023
605 LIVER DISORDER 103 0.0023
606 VASCULITIS 27 0.0023
607 STEVENS-JOHNSON SYNDROME 51 0.0023
608 EPILEPSY 70 0.0023
609 TOXICITY TO VARIOUS AGENTS 378 0.0022
610 PULMONARY OEDEMA 100 0.0022
611 UNRESPONSIVE TO STIMULI 57 0.0022
612 CELLULITIS 111 0.0022
613 WHITE BLOOD CELL COUNT ABNORMAL 14 0.0022
614 ORAL DISORDER 16 0.0022
615 THERAPY PARTIAL RESPONDER 34 0.0022
616 INTERSTITIAL LUNG DISEASE 103 0.0021
617 CARDIAC ARREST 173 0.0021
618 ANAEMIA 397 0.0021
619 EYE PAIN 116 0.0021
620 NEUROPATHY PERIPHERAL 195 0.0020
621 HAEMORRHAGIC STROKE 16 0.0020
622 MOUTH HAEMORRHAGE 15 0.0020
623 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 52 0.0020
624 EOSINOPHILIA 35 0.0020
625 DISEASE RECURRENCE 95 0.0020
626 ATRIAL FIBRILLATION 193 0.0020
627 PULMONARY TOXICITY 14 0.0020
628 WHITE BLOOD CELL COUNT DECREASED 213 0.0020
629 BLOOD POTASSIUM DECREASED 59 0.0020
630 HICCUPS 16 0.0019
631 CONCOMITANT DISEASE AGGRAVATED 12 0.0019
632 LYMPHOMA 30 0.0019
633 HYPOTENSION 385 0.0019
634 LARGE INTESTINE PERFORATION 13 0.0019
635 SINUS BRADYCARDIA 18 0.0019
636 MITRAL VALVE INCOMPETENCE 21 0.0019
637 INCOHERENT 12 0.0019
638 COLITIS 70 0.0018
639 DRUG INTOLERANCE 178 0.0018
640 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 130 0.0018
641 IMMUNODEFICIENCY 27 0.0018
642 ATRIOVENTRICULAR BLOCK COMPLETE 12 0.0018
643 RASH PUSTULAR 13 0.0018
644 INTESTINAL PERFORATION 20 0.0018
645 TRICUSPID VALVE INCOMPETENCE 14 0.0018
646 RENAL DISORDER 82 0.0018
647 RASH ERYTHEMATOUS 84 0.0018
648 ORAL CANDIDIASIS 23 0.0017
649 SKIN HYPERPIGMENTATION 15 0.0017
650 MYDRIASIS 22 0.0017
651 CONFUSIONAL STATE 276 0.0017
652 HAEMATURIA 58 0.0017
653 FULL BLOOD COUNT DECREASED 34 0.0017
654 ATRIOVENTRICULAR BLOCK 13 0.0017
655 MELAENA 37 0.0017
656 JAUNDICE 45 0.0017
657 HAEMATOCRIT DECREASED 33 0.0017
658 APHASIA 50 0.0017
659 HAEMOGLOBIN DECREASED 168 0.0016
660 CARDIO-RESPIRATORY ARREST 68 0.0016
661 CEREBRAL DISORDER 12 0.0016
662 NODULE 21 0.0016
663 URINE OUTPUT DECREASED 14 0.0016
664 DECUBITUS ULCER 13 0.0016
665 AGITATION 117 0.0016
666 MUSCLE ATROPHY 20 0.0016
667 HYPOPHAGIA 40 0.0016
668 WHITE BLOOD CELL COUNT INCREASED 60 0.0016
669 GASTROINTESTINAL INFECTION 14 0.0016
670 NO THERAPEUTIC RESPONSE 19 0.0016
671 HEPATIC STEATOSIS 29 0.0016
672 LIVE BIRTH 13 0.0016
673 CARDIAC FAILURE 124 0.0015
674 PRODUCT USE ISSUE 290 0.0015
675 DRUG TOXICITY 21 0.0015
676 SUBDURAL HAEMATOMA 22 0.0015
677 CARDIOGENIC SHOCK 22 0.0015
678 TACHYCARDIA 136 0.0015
679 GENERAL PHYSICAL HEALTH DETERIORATION 177 0.0015
680 BLOOD CREATINE PHOSPHOKINASE INCREASED 44 0.0015
681 VITREOUS FLOATERS 15 0.0015
682 DISORIENTATION 60 0.0015
683 STATUS EPILEPTICUS 17 0.0015
684 ORTHOSTATIC HYPOTENSION 26 0.0015
685 BLINDNESS UNILATERAL 21 0.0015
686 BODY TEMPERATURE INCREASED 30 0.0015
687 PRODUCT PRESCRIBING ISSUE 32 0.0015
688 TUBULOINTERSTITIAL NEPHRITIS 27 0.0014
689 RED BLOOD CELL COUNT DECREASED 41 0.0014
690 COMA 68 0.0014
691 CHOLECYSTITIS 17 0.0014
692 HYPERLIPIDAEMIA 17 0.0014
693 CARDIOMYOPATHY 21 0.0014
694 PANCREATITIS 74 0.0014
695 BONE PAIN 82 0.0014
696 BLINDNESS 57 0.0014
697 APPENDICITIS 13 0.0014
698 HAEMATOMA 36 0.0014
699 OXYGEN SATURATION DECREASED 78 0.0014
700 SMALL INTESTINAL OBSTRUCTION 17 0.0014
701 EYELID OEDEMA 16 0.0014
702 MOTOR DYSFUNCTION 14 0.0014
703 BONE DISORDER 25 0.0014
704 INTENTIONAL PRODUCT USE ISSUE 119 0.0014
705 OBSTRUCTIVE AIRWAYS DISORDER 15 0.0013
706 VISION BLURRED 185 0.0013
707 RESTLESSNESS 48 0.0013
708 DYSARTHRIA 49 0.0013
709 BRADYCARDIA 69 0.0013
710 SKIN CANCER 28 0.0013
711 GASTROINTESTINAL HAEMORRHAGE 108 0.0013
712 EJECTION FRACTION DECREASED 20 0.0013
713 THERAPEUTIC RESPONSE DECREASED 77 0.0013
714 GASTROINTESTINAL DISORDER 112 0.0012
715 BLOOD CALCIUM DECREASED 14 0.0012
716 OEDEMA 67 0.0012
717 BLOOD POTASSIUM INCREASED 20 0.0012
718 AUTOIMMUNE DISORDER 12 0.0012
719 OEDEMA PERIPHERAL 149 0.0012
720 BRAIN FOG 19 0.0012
721 BLOOD TEST ABNORMAL 17 0.0012
722 COUGH 337 0.0012
723 SKIN DISORDER 40 0.0012
724 DIALYSIS 17 0.0012
725 SKIN LACERATION 13 0.0012
726 DERMATITIS 25 0.0012
727 DYSPHAGIA 113 0.0012
728 FACE OEDEMA 20 0.0012
729 INFLAMMATION 61 0.0012
730 EYELID PTOSIS 12 0.0012
731 RED BLOOD CELL SEDIMENTATION RATE INCREASED 13 0.0012
732 STOMATITIS 71 0.0012
733 GASTROENTERITIS 17 0.0012
734 PNEUMONIA ASPIRATION 29 0.0012
735 PROTEINURIA 22 0.0012
736 NEURALGIA 28 0.0012
737 TREATMENT NONCOMPLIANCE 63 0.0012
738 MASS 16 0.0011
739 VIRAL INFECTION 38 0.0011
740 BLISTER 64 0.0011
741 CARDIOMEGALY 14 0.0011
742 HYPOGLYCAEMIA 55 0.0011
743 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 33 0.0011
744 MALIGNANT MELANOMA 15 0.0011
745 DERMATITIS ALLERGIC 14 0.0011
746 CHROMATURIA 25 0.0011
747 PULMONARY HYPERTENSION 23 0.0011
748 INTERNATIONAL NORMALISED RATIO INCREASED 31 0.0011
749 PRESCRIBED OVERDOSE 21 0.0011
750 SKIN ULCER 28 0.0011
751 LOWER RESPIRATORY TRACT INFECTION 49 0.0011
752 NEOPLASM PROGRESSION 37 0.0011
753 SARS-COV-2 TEST POSITIVE 14 0.0011
754 CONTRAINDICATED PRODUCT ADMINISTERED 32 0.0011
755 SEIZURE 122 0.0011
756 OSTEOPENIA 16 0.0011
757 BRONCHOSPASM 15 0.0011
758 DECREASED APPETITE 244 0.0010
759 LYMPHADENOPATHY 37 0.0010
760 GASTRIC HAEMORRHAGE 12 0.0010
761 PULMONARY ARTERIAL HYPERTENSION 15 0.0010
762 TASTE DISORDER 21 0.0010
763 PERICARDITIS 17 0.0010
764 DYSPNOEA EXERTIONAL 38 0.0010
765 BLOOD PRESSURE DECREASED 67 0.0010
766 DEHYDRATION 133 0.0010
767 HEPATITIS C 12 0.0010
768 ABDOMINAL PAIN 231 0.0010
769 BLOOD COUNT ABNORMAL 15 0.0010
770 MUSCULAR WEAKNESS 112 0.0010
771 DEEP VEIN THROMBOSIS 64 0.0010
772 ORAL HERPES 19 0.0010
773 BALANCE DISORDER 84 0.0010
774 ARRHYTHMIA 46 0.0010
775 DYSPNOEA 548 0.0010
776 SINUSITIS 99 0.0010
777 INTERVERTEBRAL DISC PROTRUSION 21 0.0010
778 VOMITING 449 0.0010
779 ERYTHEMA 196 0.0010
780 SPINAL FRACTURE 19 0.0009
781 LABORATORY TEST ABNORMAL 27 0.0009
782 DIARRHOEA 589 0.0009
783 HEPATIC CIRRHOSIS 17 0.0009
784 UPPER GASTROINTESTINAL HAEMORRHAGE 15 0.0009
785 UPPER RESPIRATORY TRACT INFECTION 41 0.0009
786 POST PROCEDURAL COMPLICATION 17 0.0009
787 TREMOR 146 0.0009
788 SKIN EXFOLIATION 74 0.0009
789 BLOOD PRESSURE FLUCTUATION 21 0.0009
790 ABDOMINAL DISTENSION 91 0.0009
791 PLASMA CELL MYELOMA 34 0.0009
792 CHILLS 101 0.0009
793 COGNITIVE DISORDER 40 0.0009
794 FREQUENT BOWEL MOVEMENTS 23 0.0009
795 CYSTITIS 27 0.0008
796 HEART RATE INCREASED 84 0.0008
797 DIPLOPIA 22 0.0008
798 DEATH 727 0.0008
799 DEAFNESS 22 0.0008
800 FEEDING DISORDER 17 0.0008
801 LACTIC ACIDOSIS 27 0.0008
802 HAEMORRHAGE 87 0.0008
803 CHOLELITHIASIS 27 0.0008
804 HERPES ZOSTER 47 0.0008
805 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 14 0.0008
806 HYPOTHYROIDISM 26 0.0008
807 ACUTE MYOCARDIAL INFARCTION 24 0.0008
808 MYALGIA 138 0.0008
809 CONSTIPATION 177 0.0008
810 ORAL PAIN 18 0.0008
811 RASH PAPULAR 18 0.0008
812 INFUSION RELATED REACTION 53 0.0008
813 BLOOD SODIUM DECREASED 15 0.0008
814 ACCIDENTAL OVERDOSE 29 0.0008
815 EPISTAXIS 59 0.0008
816 DYSURIA 29 0.0008
817 FAECES DISCOLOURED 17 0.0008
818 BRONCHITIS 58 0.0008
819 LETHARGY 45 0.0008
820 ASTHENIA 292 0.0008
821 RENAL INJURY 23 0.0008
822 MALIGNANT NEOPLASM PROGRESSION 79 0.0008
823 INFLUENZA 86 0.0008
824 CONVULSION 44 0.0008
825 HAEMORRHOIDS 15 0.0008
826 ANGIOEDEMA 34 0.0008
827 CYANOSIS 12 0.0008
828 GASTRITIS 20 0.0008
829 MUSCULOSKELETAL DISCOMFORT 13 0.0008
830 COVID-19 132 0.0008
831 HAEMATEMESIS 19 0.0007
832 HYPERTENSION 158 0.0007
833 RASH 323 0.0007
834 MUSCLE TWITCHING 17 0.0007
835 FLUID RETENTION 37 0.0007
836 CONJUNCTIVITIS 13 0.0007
837 NAUSEA 553 0.0007
838 CHEST PAIN 129 0.0007
839 NIGHTMARE 24 0.0007
840 URINARY TRACT INFECTION 118 0.0007
841 HYPOAESTHESIA 103 0.0007
842 GAIT DISTURBANCE 130 0.0007
843 PULMONARY FIBROSIS 13 0.0007
844 TOOTH DISORDER 15 0.0007
845 ANAPHYLACTIC REACTION 37 0.0007
846 BLOOD PRESSURE SYSTOLIC INCREASED 13 0.0007
847 LIMB INJURY 18 0.0007
848 LOCALISED INFECTION 16 0.0007
849 PRESYNCOPE 16 0.0007
850 CHEST DISCOMFORT 67 0.0007
851 RESPIRATORY ARREST 18 0.0007
852 WEIGHT DECREASED 182 0.0007
853 HYPOACUSIS 28 0.0006
854 SPEECH DISORDER 33 0.0006
855 SOMNOLENCE 126 0.0006
856 PULMONARY EMBOLISM 59 0.0006
857 LOSS OF CONSCIOUSNESS 79 0.0006
858 PSYCHOTIC DISORDER 18 0.0006
859 PARAESTHESIA 93 0.0006
860 CARDIOVASCULAR DISORDER 15 0.0006
861 WHEEZING 35 0.0006
862 NIGHT SWEATS 19 0.0006
863 PALLOR 16 0.0006
864 SWELLING FACE 38 0.0006
865 DRUG EFFECT INCOMPLETE 21 0.0006
866 SEDATION 15 0.0006
867 SYNCOPE 57 0.0006
868 SYSTEMIC LUPUS ERYTHEMATOSUS 20 0.0006
869 AGGRESSION 28 0.0006
870 DIABETES MELLITUS 41 0.0005
871 MENTAL IMPAIRMENT 13 0.0005
872 THROMBOSIS 43 0.0005
873 HOSPITALISATION 82 0.0005
874 NASAL CONGESTION 31 0.0005
875 ALOPECIA 103 0.0005
876 CATARACT 31 0.0005
877 INSOMNIA 138 0.0005
878 EYE DISORDER 17 0.0005
879 MUSCULOSKELETAL PAIN 27 0.0005
880 COLITIS ULCERATIVE 23 0.0005
881 HEADACHE 320 0.0005
882 ARTHRITIS 40 0.0005
883 HAEMATOCHEZIA 28 0.0005
884 NEPHROLITHIASIS 23 0.0005
885 LACRIMATION INCREASED 15 0.0005
886 PAIN IN JAW 14 0.0005
887 MATERNAL EXPOSURE DURING PREGNANCY 44 0.0005
888 FALL 162 0.0005
889 OSTEOPOROSIS 20 0.0005
890 EXTRAPYRAMIDAL DISORDER 12 0.0005
891 OVERDOSE 104 0.0005
892 FATIGUE 375 0.0005
893 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 25 0.0005
894 ASTHMA 54 0.0005
895 DISTURBANCE IN ATTENTION 25 0.0005
896 RASH PRURITIC 25 0.0005
897 CHRONIC KIDNEY DISEASE 35 0.0005
898 VERTIGO 28 0.0005
899 RASH MACULAR 16 0.0005
900 BACK PAIN 106 0.0005
901 HEART RATE DECREASED 16 0.0005
902 ABNORMAL BEHAVIOUR 18 0.0005
903 HYPERSOMNIA 13 0.0005
904 WEIGHT INCREASED 101 0.0005
905 CARDIAC FAILURE CONGESTIVE 36 0.0004
906 ARTHRALGIA 185 0.0004
907 ILL-DEFINED DISORDER 27 0.0004
908 OROPHARYNGEAL PAIN 41 0.0004
909 HEAD INJURY 14 0.0004
910 ABDOMINAL DISCOMFORT 73 0.0004
911 LIP SWELLING 14 0.0004
912 URINARY RETENTION 14 0.0004
913 DIZZINESS 207 0.0004
914 SLEEP DISORDER 29 0.0004
915 HYPERSENSITIVITY 76 0.0004
916 MOVEMENT DISORDER 13 0.0004
917 MEMORY IMPAIRMENT 55 0.0004
918 DEPRESSION 91 0.0004
919 INTESTINAL OBSTRUCTION 15 0.0004
920 OSTEONECROSIS 13 0.0004
921 CONTUSION 38 0.0004
922 ABDOMINAL PAIN UPPER 81 0.0004
923 DRUG ADMINISTRATION ERROR 12 0.0004
924 ADVERSE DRUG REACTION 35 0.0004
925 RHINORRHOEA 25 0.0004
926 POLLAKIURIA 16 0.0004
927 HIP FRACTURE 12 0.0004
928 FLATULENCE 21 0.0004
929 PAIN IN EXTREMITY 109 0.0004
930 HYPERHIDROSIS 47 0.0004
931 SWELLING 34 0.0004
932 PERIPHERAL SWELLING 55 0.0004
933 THERAPEUTIC RESPONSE UNEXPECTED 16 0.0004
934 EYE SWELLING 13 0.0003
935 MALAISE 153 0.0003
936 ADVERSE EVENT 32 0.0003
937 NERVOUSNESS 18 0.0003
938 DYSKINESIA 14 0.0003
939 MEDICATION ERROR 19 0.0003
940 NO ADVERSE EVENT 61 0.0003
941 UNEVALUABLE EVENT 25 0.0003
942 BURNING SENSATION 23 0.0003
943 SKIN DISCOLOURATION 15 0.0003
944 DYSPHONIA 19 0.0003
945 PALPITATIONS 38 0.0003
946 DRY MOUTH 26 0.0003
947 INFLUENZA LIKE ILLNESS 26 0.0003
948 DRUG EFFECT DECREASED 17 0.0003
949 THROAT IRRITATION 14 0.0003
950 DISCOMFORT 19 0.0003
951 MUSCLE SPASMS 56 0.0003
952 CEREBROVASCULAR ACCIDENT 51 0.0003
953 PAIN 181 0.0003
954 AMNESIA 19 0.0003
955 BLOOD PRESSURE INCREASED 44 0.0003
956 MOBILITY DECREASED 20 0.0003
957 CARDIAC DISORDER 26 0.0003
958 INTENTIONAL PRODUCT MISUSE 24 0.0003
959 OCULAR HYPERAEMIA 13 0.0003
960 ILLNESS 28 0.0003
961 NASOPHARYNGITIS 49 0.0003
962 DRY EYE 13 0.0003
963 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 46 0.0003
964 BLOOD GLUCOSE INCREASED 48 0.0003
965 PRODUCT DOSE OMISSION ISSUE 73 0.0002
966 PRURITUS 95 0.0002
967 FOETAL EXPOSURE DURING PREGNANCY 20 0.0002
968 PRODUCT DOSE OMISSION 16 0.0002
969 DYSPEPSIA 24 0.0002
970 EXPOSURE DURING PREGNANCY 15 0.0002
971 ANXIETY 68 0.0002
972 URTICARIA 40 0.0002
973 THERAPY INTERRUPTED 16 0.0002
974 GASTROOESOPHAGEAL REFLUX DISEASE 18 0.0002
975 SURGERY 13 0.0002
976 JOINT SWELLING 26 0.0002
977 DYSGEUSIA 16 0.0002
978 NEOPLASM MALIGNANT 14 0.0002
979 FEELING ABNORMAL 50 0.0002
980 EYE IRRITATION 12 0.0002
981 ACNE 15 0.0002
982 UNDERDOSE 14 0.0002
983 EMOTIONAL DISTRESS 23 0.0002
984 SUICIDAL IDEATION 17 0.0002
985 DRY SKIN 24 0.0002
986 ACCIDENTAL EXPOSURE TO PRODUCT 18 0.0002
987 FLUSHING 17 0.0002
988 INCORRECT DOSE ADMINISTERED 37 0.0002
989 MYOCARDIAL INFARCTION 28 0.0002
990 MIGRAINE 14 0.0001
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 29 0.0001
992 INJECTION SITE PAIN 12 0.0000